Aldose reductase regulates TNF-α-induced cell signaling and apoptosis in vascular endothelial cells

FEBS Letters

Volumn 570, Issue 1-3, 2004, Pages 189-194

  Ramana, Kota V ^a   Bhatnagar, Aruni ^b   Srivastava, Satish K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Aldose reductase; AP 1; Apoptosis; Bcl 2; Endothelial cell; TNF

Indexed keywords

ALDEHYDE REDUCTASE; SORBINIL; TOLRESTAT; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ALDEHYDE REDUCTASE; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASES; CELL NUCLEUS; CELL SURVIVAL; CELLS, CULTURED; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; HUMANS; IMIDAZOLES; IMIDAZOLIDINES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 3142646780     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2004.06.046     Document Type: Article

References (22)

1. Choy J.C., Granville D.J., Hunt D.W., McManus B.M. J. Mol. Cell. Cardiol. 33:2001;1673-1690
2. Valgimigli M., Merli E., Malagutti P., Soukhomovskaia O., Cicchitelli G., Macri G., Ferrari R. Arch. Biochem. Biophys. 420:2003;255-261
3. Haimovitz-Friedman A., Cordon-Cardo C., Bayoumy S., Garzotto M., McLoughlin M., Gallily R., Edwards C.K. III, Schuchman E.H., Fuks Z., Kolesnick R. J. Exp. Med. 186:1997;1831-1841
4. Zheng L., Dengler T.J., Kluger M.S., Madge L.A., Schechner J.S., Maher S.E., Pober J.S., Bothwell A.L. J. Immunol. 164:2000;4665-4671
5. Ferrari R., Bachetti T., Agnoletti L., Comini L., Curello S. Eur. Heart J. 19:1998;G41-G47
6. Lusis A.J., Glass C.K., Witzum J.L. Cell. 104:2001;503-516
7. Deshpande S.S., Angkeow P., Huang J., Ozaki M., Irani K. FASEB J. 14:2000;1705-1714
8. Hall J.L., Wang X., Van Adamson V., Zhao Y., Gibbons G.H. Circ. Res. 2001;1223-1225
9. Ramana K.V., Chandra D., Srivastava S., Bhatnagar A., Aggarwal B.B., Srivastava S.K. J. Biol. Chem. 277:2002;32063-32070
10. Ruef J., Liu S.Q., Bode C., Tocchi M., Srivastava S., Runge M.S., Bhatnagar A. Arterioscler. Thromb. Vasc. Biol. 20:2000;1745-1752
11. Shinmura K., Bolli R., Liu S.Q., Tang X.L., Kodani E., Xuan Y.T., Srivastava S., Bhatnagar A. Circ. Res. 91:2002;240-246
12. Vander Jagt D.L., Kolb N.S., Vander Jagt T.J., Chino J., Martinez F.J., Hunsaker L.A., Royer R.E. Biochim. Biophys. Acta. 1249:1995;117-126
13. Srivastava S., Watowich S.J., Petrash J.M., Srivastava S.K., Bhatnagar A. Biochemistry. 38:1999;42-54
14. Rittner H.L., Hafner V., Klimiuk P.A., Szweda L.I., Goronzy J.J., Weyand C.M. J. Clin. Invest. 103:1999;1007-1013
15. Ramana K.V., Friedrich B., Bhatnagar A., Srivastava S.K. FASEB J. 17:2003;315-317
16. Galvez A.S., Ulloa J.A., Chiong M., Criollo A., Eisner V., Barros L.F., Lavandero S. J. Biol. Chem. 278:2003;38484-38494
17. Liu Z-G., Hsu H., Goeddel D.V., Karin M. Cell. 87:1996;565-576
18. Natoli G., Constanzo A., Ianni A., Templeton D.J., Woodgett J.R., Balsano C., Levrero M. Science. 275:1997;200-203
19. Manna S.K., Mukhopadhyay A, Aggarwal B.B. J. Immunol. 164:2000;6509-6519
20. Breitschopf K., Haendeler J., Malchow P., Zeiher A.M., Dimmeler S. Mol. Cell. Biol. 20:2000;1886-1896
21. Bhatnagar A., Srivastava S.K. Biochem. Med. Metabol. Biol. 48:1992;91-121
22. Yabe-Nishimura C. Pharmacol. Rev. 50:1998;21-33